Skip to content
★ Sign in to follow
XP

Xvivo Perfusion AB Stock: price and insider trades · Sweden

No insider purchase over the last 90 days. The latest, by Christoffer Björn Rosenblad, was filed 31 May 2022.

Xvivo Perfusion AB: what insiders have been doing

This page follows insider dealings at Xvivo Perfusion AB as filed with Finansinspektionen. Nothing new has been filed by managers of Xvivo Perfusion AB in twelve months, the latest record being from 31 May 2022.

The full history, which starts in 2017, counts 3 purchases against 2 sales.

In the same market, recent insider purchases at Linc AB and Dynavox Group AB also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€26,766
3 ops. · all time
Sell Volume
€267,171
2 ops. · all time

Since the insiders bought

  • Filed 11 Jun 2017 · 3437 days ago · €6,466
    +8.4%
    Entry 11.77 · Close at T+365 12.76
  • Filed 08 Jun 2017 · 3440 days ago · €3,233
    +8.4%
    Entry 11.77 · Close at T+365 12.76

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

· cache

Last declaration on 31 May 2022
Declarations9 total
  • ▲
    Vice VDExecutives
    179,200 SEK0FI-SE
    10,000 shares@ SEK 17.9212.7% of flowTeckningsoptionFI:csv-addf7c71f99c512bb6bc
    Canonical exit: 29 Aug 2022 (T+90)
  • ●
    Ekonomichef/finanschef/finansdirektörExecutives
    81,550 SEK0FI-SE
    5,000 shares@ SEK 16.31100.0% of flowTeckningsoptionFI:csv-aa702d725fe8fa0f6a51
  • ●
    Vice VDExecutives
    122,325 SEK0FI-SE
    7,500 shares@ SEK 16.319.8% of flowTeckningsoptionFI:csv-41b878962d28b62ea5b1
  • ●
    Vice VD,Ekonomi/finanschefExecutives
    11,763 SEK22FI-SE
    18,000 shares@ SEK 0.65351.2% of flowFI:csv-d0f39e7163b55ffb6cda
  • ●
    VDExecutives
    23,526 SEK22FI-SE
    36,000 shares@ SEK 0.65351.2% of flowFI:csv-c68b94a2a847bb9aa0d4
  • ▼
    VDExecutives
    2M SEK42FI-SE
    50,500 shares@ SEK 34.3395.3% of flowFI:csv-20ce0fca6d4b7c819f8e
  • ▲
    VDExecutives
    63,000 SEK34FI-SE
    36,000 shares@ SEK 1.753.5% of flowFI:csv-417f52f3ebd7e36f9937
    Canonical exit: 3 Sept 2017 (T+90)
  • ▲
    Ekonomi/finanschefExecutives
    31,500 SEK19FI-SE
    18,000 shares@ SEK 1.753.5% of flowFI:csv-227c0bd81620ab00d4ca
    Canonical exit: 3 Sept 2017 (T+90)
  • ▼
    Ekonomi/finanschefExecutives
    868,821 SEK27FI-SE
    26,000 shares@ SEK 33.416295.3% of flowFI:csv-695ee808017906adc9a5

9 of 9 declarations

About Xvivo Perfusion AB

Xvivo Perfusion AB is a company focused on developing perfusion solutions for transplanted organs. It is listed on the Stockholm Stock Exchange.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations